|
|
||||||||
Published online before print October 19, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis
,
,
@
*Department of Molecular Bioscience, School of Bioscience and Biotechnology, and
Vascular System Research Center, Kangwon National University, Chunchon, Korea
@ To whom correspondence should be addressed. E-mail: phkim{at}kangwon.ac.kr.
| Abstract |
|---|
TGF-
induces vascular endothelial growth factor (VEGF), a potent angiogenic factor, at the transcriptional and protein levels in mouse macrophages. VEGF secretion in response to TGF-
1 is enhanced by hypoxia and by overexpression of Smad3/4 and hypoxia-inducible factor-1
/
(HIF-1
/
). To examine the transcriptional regulation of VEGF by TGF-
1, we constructed mouse reporters driven by the VEGF promoter. Overexpression of HIF-1
/
or Smad3/4 caused a slight increase of VEGF promoter activity in the presence of TGF-
1, whereas cotransfection of HIF-1
/
and Smad3/4 had a marked effect. Smad2 was without effect on this promoter activity, whereas Smad7 markedly reduced it. Analysis of mutant promoters revealed that the one putative HIF-1 and two Smad-binding elements were critical for TGF-
1-induced VEGF promoter activity. The relevance of these elements was confirmed by chromatin immunoprecipitation assay. p300, which has histone acetyltransferase activity, augmented transcriptional activity in response to HIF-1
/
and Smad3/4, and E1A, an inhibitor of p300, inhibited it. TGF-
1 also increased the expression of fetal liver kinase-1 (Flk-1), a major VEGF receptor, and TGF-
1 and VEGF stimulated pro-matrix metalloproteinase 9 (MMP-9) and active-MMP-9 expression, respectively. The results from the present study indicate that TGF-
1 can activate mouse macrophages to express angiogenic mediators such as VEGF, MMP-9, and Flk-1.
Key Words: MMP-9 HUVEC promoter
This article has been cited by other articles:
![]() |
L. D. Moore, T. Isayeva, G. P. Siegal, and S. Ponnazhagan Silencing of Transforming Growth Factor-{beta}1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo Clin. Cancer Res., August 1, 2008; 14(15): 4961 - 4970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-A Kim, S.-H. Jeon, G.-Y. Seo, J.-B. Park, and P.-H. Kim TGF-{beta}1 and IFN-{gamma} stimulate mouse macrophages to express BAFF via different signaling pathways J. Leukoc. Biol., June 1, 2008; 83(6): 1431 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S.R. Maharaj, T. E. Walshe, M. Saint-Geniez, S. Venkatesha, A. E. Maldonado, N. C. Himes, K. S. Matharu, S. A. Karumanchi, and P. A. D'Amore VEGF and TGF-{beta} are required for the maintenance of the choroid plexus and ependyma J. Exp. Med., February 18, 2008; 205(2): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishida, J.-L. Gao, and P. M. Murphy Chemokine Receptor CX3CR1 Mediates Skin Wound Healing by Promoting Macrophage and Fibroblast Accumulation and Function J. Immunol., January 1, 2008; 180(1): 569 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Yeh, D.-Y. Lu, C.-J. Lin, H.-C. Liou, and W.-M. Fu Inhibition of Hypoxia-Induced Increase of Blood-Brain Barrier Permeability by YC-1 through the Antagonism of HIF-1{alpha} Accumulation and VEGF Expression Mol. Pharmacol., August 1, 2007; 72(2): 440 - 449. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |